JP Morgan Call 80 MDT 16.08.2024/ DE000JK7AYN4 /
| 2024-05-22 8:47:56 AM | Chg.- | Bid1:08:35 PM | Ask1:08:35 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.640EUR | - | - Bid Size: - |
- Ask Size: - |
Medtronic PLC | 80.00 USD | 2024-08-16 | Call |
GlobeNewswire
05-13
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
05-09
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for im...
GlobeNewswire
04-30
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...
GlobeNewswire
04-23
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
GlobeNewswire
04-23
Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa...
GlobeNewswire
03-27
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market G...
GlobeNewswire
03-26
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...
GlobeNewswire
03-13
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...
GlobeNewswire
03-06
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemod...
GlobeNewswire
02-26
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambu...
GlobeNewswire
02-05
Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herber...
GlobeNewswire
01-08
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pace...
GlobeNewswire
2023-12-29
Visionary Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its ...
GlobeNewswire
2023-11-13
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
